Patients Benefit from Non-Surgical SRT
If you’ve been diagnosed with non-melanoma skin cancer, such as basal cell carcinoma or squamous cell carcinoma, you now have a new, non-surgical option for treatment. Superficial Radio Therapy (SRT) with the SRT-100™ delivers a precise, calibrated dose of SRT that only goes skin deep. This low-dose of Superficial Radio Therapy safely destroys non-melanoma skin […]
Physicians Prefer SRT Therapy for Treatment of Non-Melanoma Skin Cancer and Keloid Scars
Eighteen million people are affected by unsightly and sometimes painful keloid scars, and many of them go through life believing treatment for this embarrassing condition is next to impossible, if possible at all. You can help restore your patient’s confidence and self-esteem by offering keloid treatment with Superficial Radio Therapy (SRT therapy) following surgical removal. […]
Sensus Healthcare to Announce Third Quarter 2016 Results on November 3, 2016
BOCA RATON, Fla., Oct. 20, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its third quarter 2016 financial results on Thursday, November 3, 2016 after the market […]
New study highlights need for routine skin cancer screening for all transplant patients
Drexel University College of Medicine study suggests all organ transplant recipients should receive total-body screenings for skin cancer
Sensus Healthcare to Participate in Important Dermatological and Institutional Investor Conferences from October 20th to October 23rd
–2016 Fall Clinical Dermatology Conference in Las Vegas, NV –Dawson James 2016 Small Cap Growth Stock Conference in Jupiter, FL BOCA RATON, Fla., Oct. 6, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy […]
